C2C - Drug Repurposing: Opportunities and Challenges in Today’s Health Care Environment
About this Event
Join U Innovation as we welcome Stever Glover, CoFounder and CEO of ZyVersa, a UM spinout company, as he discusses the opportunites available and the unique challenges of bringing to market repurposed drugs. Repurposed drugs are those that were originally developed and often marketed for a different disease or condition. This seminar is relevant to researchers and clinicians looking into treatments for a wide variety of diseases, such as those that may share underlying biology with other treated disorders.
